Literature DB >> 33798523

Targeting the Myeloid-Derived Suppressor Cell Compartment for Inducing Responsiveness to Immune Checkpoint Blockade Is Best Limited to Specific Subtypes of Gastric Cancers.

Liudmila L Kodach1, Maikel P Peppelenbosch2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33798523     DOI: 10.1053/j.gastro.2021.03.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Comprehensive comparison of theranostic nanoparticles in breast cancer.

Authors:  Amin Nikdouz; Nima Namarvari; Ramin Ghasemi Shayan; Arezoo Hosseini
Journal:  Am J Clin Exp Immunol       Date:  2022-02-15

2.  Gene Polymorphisms of m6A Erasers FTO and ALKBH1 Associated with Susceptibility to Gastric Cancer.

Authors:  Yue Li; Dalei Zhou; Qing Liu; Weijie Zhu; Zulu Ye; Caiyun He
Journal:  Pharmgenomics Pers Med       Date:  2022-05-31

3.  Phosphoserine phosphatase as a prognostic biomarker in patients with gastric cancer and its potential association with immune cells.

Authors:  Ma-Yan Huang; Xiao-Yun Liu; Qiong Shao; Xu Zhang; Lei Miao; Xiao-Yan Wu; Yu-Xia Xu; Fang Wang; Hai-Yun Wang; Liang Zeng; Ling Deng
Journal:  BMC Gastroenterol       Date:  2022-01-03       Impact factor: 3.067

4.  RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism.

Authors:  Man Liu; Hongxia Zhang; Lu Zhang; Xin Liu; Simin Zhou; Xiaoyi Wang; Weilong Zhong; Jie Zhang; Bangmao Wang; Jingwen Zhao; Lu Zhou
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

5.  A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.

Authors:  Jingxian Li; Xun Liu; Yuanjiong Qi; Yang Liu; E Du; Zhihong Zhang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.